Digital pathology: The next big thing in medical technology

 Digital pathology incorporates the accession, sharing and operation of pathology information, including data in digital sides are created when glass slides are captured with a scanning device, digital image that can be viewed on a computer screen, gain more knowledge join us 11th Emirates Pathology & Digital Pathology Utilitarian Conference on May 9-10, 2022, Online

Benefit of digital pathology

 Pathology starts with a collected tissues Glass slides are necessary, even if they're latter transferred to a digital scan. But today’s pathology goes beyond tissue

 Today’s pathology needs new approaches. And when pathologists stop short of espousing digital pathology fully, they miss out on the benefits that cannot be achieved with glass slides.

 Improved analysis:

Ø  Algorithms for analysing slides are adjective accurate and quicker than microscopy

Ø  Rapid access to prior cases

Better Views

Ø  Capability to measure multiple AOI

Ø  Allows for team annotation of slides

Ø  Provides a dashboard view of data and annotation

Improved Workflow

Ø  Fosters collaboration

Ø  Central Steers  enables easy access in streamlined workflow

Ø  Checks trend toward outsourcing

Ø  Flex work schedules and remote access

. Reduced Turnaround Times

Ø  Faster access to archived digital slides

Ø  Reduces time reacquiring, data matching and organizing

 

Digital pathology is increasingly used by large biopharmaceuticals and top clinical exploration associations (CROs) to streamline medicine development processes in discovery,pre-clinical and clinical trials.

Particular opportunity exists for the implicit future use of digital pathology for quantitative analysis of arising companion diagnostics and new theranostics. This opportunity may come especially applicable with the arrival of assays which are delicate to discern with the human eye, similar as multiplex, or labels which exhibit verbose staining characteristics across multiple cellular of which, for illustration, only one may be clinically relevant

 The adding complexity of such assays is driving the development of digital pathology results with advanced high- outturn image capture (brightfield, fluorescent or multispectral) coupled with pattern recognition to morphologically identify applicable tissue types and individual cellular compartments followed by the capability to quantify (IHC) intensity of staining.

This is leading to the arrival of digital pathology systems that can offer a clinically relevant diagnostic or prognostic score by comparing sample analysis affair against a standard curve derived from clinical data. Indeed, much of the untapped eventuality of digital pathology may be in the implicit capability to diagnostic or prognostic scores by combining IHC data and images with that of other